The long haul of long Covid
The challenge for scientists globally in finding a treatment for long Covid.
Three years after the official declaration of a pandemic, 65 million people - one in 10 who had Covid-19 - still have symptoms. Some are so ill they are yet to return to work.
The Economist’s health editor, Natasha Loder, examines the science behind long Covid and hears about the challenges as researchers try to unravel the cause behind a condition associated with around 200 symptoms.
Natasha gains insights about the disease from Dr Walter Koroshetz, co-director of the long Covid Recover study in the United States, pulmonologist Dr Lancelot Pinto in Mumbai, India, and long Covid expert Dr Waasila Jassat in Johannesburg, South Africa.
She also meets Dr Emma Wall at London’s Francis Crick Institute to hear about the UK’s long Covid drug trial and Dr Maria Teresa Ferretti, from the Women’s Brain Project, discusses why women are twice as likely to get long Covid than men.
(Photo: Ghenya Grondin, who first was sick with Covid-19 in March 2020 and has had long Covid ever since. Crredit: Brian Snyder/Reuters)
Last on
Broadcasts
- Tue 7 Mar 2023 02:32GMTΒι¶ΉΤΌΕΔ World Service
- Tue 7 Mar 2023 09:32GMTΒι¶ΉΤΌΕΔ World Service
- Tue 7 Mar 2023 20:06GMTΒι¶ΉΤΌΕΔ World Service Americas and the Caribbean, UK DAB/Freeview, Europe and the Middle East & Online only
- Tue 7 Mar 2023 21:06GMTΒι¶ΉΤΌΕΔ World Service except Online, Americas and the Caribbean, Europe and the Middle East & UK DAB/Freeview
- Sun 12 Mar 2023 05:32GMTΒι¶ΉΤΌΕΔ World Service